LUNGUARD

Founded in October 2008, LunGuard is a device based company engaged in developing a novel Peristaltic Feeding Tube (PFT) catering to hospitalized patients in Intensive Care Units (ICU). The purpose of the PFT is two fold: to act as an improved lumen feeding tube, in addition to being a preventive measure to Ventilator Associated Pneumonia (VAP). VAP is the leading cause of morbidity and mortality in intensive care units (ICU’s) and LunGuard’s innovative PFT device may significantly reduce the incidences of VAP, translating into shorter hospitalization periods, better ICU medical care and reduced mortality cases.